Purchases and Sales Made in Q1 2024 in Anebulo Pharmaceuticals, Inc. (ANEB)
This table provides information about the institutional ownership of Anebulo Pharmaceuticals, Inc. (ANEB) during Q1 2024. The information is specifically focused on institutions that hold shares of Anebulo Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 07, 2024
Q1 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
25.3KNew |
$59.1K - $75.8K
|
25.3K
$40.9K
|
|
May 13, 2024
Q1 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
22.8KNew |
$53.3K - $68.3K
|
22.8K
$36.9K
|
|
May 10, 2024
Q1 2024
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
469+ 0.31% |
$1.1K - $1.41K
|
153K
$249K
|
|
May 13, 2024
Q1 2024
|
Ubs Group Ag
|
BUY
|
- |
144New |
$337 - $432
|
144
$233
|
|
May 10, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
9New |
$21.1 - $27
|
9
$14.6
|
|
May 10, 2024
Q1 2024
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
1+ 1.64% |
$2.34 - $3
|
62
$100
|
|
Apr 30, 2024
Q1 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 05, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-13- 25.49% |
$30.4 - $39
|
38
$61.6
|
|
May 15, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-33- 46.48% |
$77.2 - $99
|
38
$61.6
|
|
May 10, 2024
Q1 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-96- 2.32% |
$225 - $288
|
4.05K
$6.56K
|
|
Apr 17, 2024
Q1 2024
|
Lvw Advisors, LLC
|
SELL
|
- |
-1K- 0.16% |
$2.34K - $3K
|
642K
$1.04M
|
|
May 15, 2024
Q1 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-3.96K- 43.55% |
$9.28K - $11.9K
|
5.14K
$8.32K
|